Long-term experience with a low-dose oral contraceptive.

Area of Science:

• Reproductive Health
• Pharmacology

Background:

• Oral contraception is a highly effective reversible fertility control method.
• Over 25 years, research identified risks and non-contraceptive benefits of oral contraceptives.
• New formulations aim to enhance tolerance, cycle control, and metabolic impact.

Purpose of the Study:

• To develop safer hormonal contraceptives with minimal side effects.
• To maintain contraceptive effectiveness while improving patient tolerance.
• To meet modern low-dose oral contraception criteria through new substances and reduced dosages.

Main Methods:

• Extensive research and epidemiological studies.
• Development of new hormonal contraceptive formulations.
• Clinical experience with Femovan.

Main Results:

• Significant reduction in side effects associated with oral contraception.
• Lowered risks potentially involved with oral contraceptive use.
• Achievement of modern low-dose oral contraception criteria.

Conclusions:

• Extensive research has successfully reduced side effects and risks of oral contraceptives.
• New formulations, like Femovan, demonstrate improved safety and efficacy.
• Modern low-dose oral contraceptives meet established criteria for patient well-being.